The RA group shows higher gene expression levels in RAD51B, BRCA1, and BRCA2 than the control group (median of 0.00213 vs. 0.0069; 0.004 vs. 0.008; 0.00057 vs. 0.001; p < 0.05). The gene discussed is RAD51B; the disease is rheumatoid arthritis.